Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer.

Stenzinger A, Wittschieber D, von Winterfeld M, Goeppert B, Kamphues C, Weichert W, Dietel M, Rabien A, Klauschen F.

Hum Pathol. 2012 Sep;43(9):1471-81. doi: 10.1016/j.humpath.2011.10.023. Epub 2012 Mar 12.

PMID:
22417846
[PubMed - indexed for MEDLINE]
2.

Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.

Dalberg K, Eriksson E, Enberg U, Kjellman M, Bäckdahl M.

World J Surg. 2000 Mar;24(3):334-40.

PMID:
10658069
[PubMed - indexed for MEDLINE]
3.

Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.

Buergy D, Fuchs T, Kambakamba P, Mudduluru G, Maurer G, Post S, Tang Y, Nakada MT, Yan L, Allgayer H.

Cancer. 2009 Oct 15;115(20):4667-78. doi: 10.1002/cncr.24516.

PMID:
19569245
[PubMed - indexed for MEDLINE]
Free Article
4.

EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.

Ju XZ, Yang JM, Zhou XY, Li ZT, Wu XH.

Clin Cancer Res. 2008 Jan 15;14(2):494-501. doi: 10.1158/1078-0432.CCR-07-1072.

PMID:
18223224
[PubMed - indexed for MEDLINE]
Free Article
5.
6.

EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.

Boye K, Nesland JM, Sandstad B, Haugland Haugen M, Mælandsmo GM, Flatmark K.

Br J Cancer. 2012 Aug 7;107(4):667-74. doi: 10.1038/bjc.2012.293. Epub 2012 Jul 10.

PMID:
22782346
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9.

Sienel W, Polzer B, Elshawi K, Lindner M, Morresi-Hauf A, Vay C, Eder F, Passlick B, Klein CA.

Mod Pathol. 2008 Sep;21(9):1130-8. doi: 10.1038/modpathol.2008.102. Epub 2008 Jun 20.

PMID:
18567995
[PubMed - indexed for MEDLINE]
Free Article
8.

Extracellular matrix metalloproteinase inducer is a negative prognostic factor of pediatric medulloblastoma.

Chu T, Chen X, Yu J, Xiao J, Fu Z.

Pathol Oncol Res. 2011 Sep;17(3):705-11. doi: 10.1007/s12253-011-9373-z. Epub 2011 Mar 31.

PMID:
21448785
[PubMed - indexed for MEDLINE]
9.

Reversion-inducing cysteine-rich protein with Kazal motif (RECK) expression: an independent prognostic marker of survival in colorectal cancer.

Stenzinger A, von Winterfeld M, Rabien A, Warth A, Kamphues C, Dietel M, Weichert W, Klauschen F, Wittschieber D.

Hum Pathol. 2012 Aug;43(8):1314-21. doi: 10.1016/j.humpath.2011.10.012. Epub 2012 Mar 6.

PMID:
22397871
[PubMed - indexed for MEDLINE]
10.

Expression and clinical significance of CD147 in genitourinary carcinomas.

Han ZD, He HC, Bi XC, Qin WJ, Dai QS, Zou J, Ye YK, Liang YX, Zeng GH, Zhu G, Chen ZN, Zhong WD.

J Surg Res. 2010 May 15;160(2):260-7. doi: 10.1016/j.jss.2008.11.838. Epub 2008 Dec 10.

PMID:
19286191
[PubMed - indexed for MEDLINE]
11.

Expression of matrix metalloproteinase 2 and extracellular matrix metalloproteinase inducer are unfavorable postoperative prognostic factors in intrahepatic cholangiocarcinoma.

Zhang C, Tu Z, Du S, Wang Y, Wang Q.

Pathol Oncol Res. 2010 Mar;16(1):47-53. doi: 10.1007/s12253-009-9186-5. Epub 2009 Jul 25.

PMID:
19629755
[PubMed - indexed for MEDLINE]
12.

EMMPRIN/CD147 expression is associated with disease-free survival of patients with colorectal cancer.

Zhu S, Chu D, Zhang Y, Wang X, Gong L, Han X, Yao L, Lan M, Li Y, Zhang W.

Med Oncol. 2013 Mar;30(1):369. doi: 10.1007/s12032-012-0369-7. Epub 2013 Feb 7.

PMID:
23389916
[PubMed - indexed for MEDLINE]
13.

EMMPRIN expression in tongue squamous cell carcinoma.

Huang Z, Huang H, Li H, Chen W, Pan C.

J Oral Pathol Med. 2009 Jul;38(6):518-23. doi: 10.1111/j.1600-0714.2009.00775.x. Epub 2009 Apr 13.

PMID:
19473445
[PubMed - indexed for MEDLINE]
14.

[Expressions of CD147 and matrix metalloproteinase-2 in breast cancer and their correlations to prognosis].

Zhou S, Liu C, Wu SM, Wu RL.

Ai Zheng. 2005 Jul;24(7):874-9. Chinese.

PMID:
16004819
[PubMed - indexed for MEDLINE]
15.

Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients.

Du ZM, Hu CF, Shao Q, Huang MY, Kou CW, Zhu XF, Zeng YX, Shao JY.

Int J Cancer. 2009 Oct 15;125(8):1832-41. doi: 10.1002/ijc.24531.

PMID:
19582878
[PubMed - indexed for MEDLINE]
16.

[Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and clinical significance].

Gou XX, Jin F, Chen HX, Wu WL, Chen L, Zeng Y.

Zhonghua Yi Xue Za Zhi. 2010 May 11;90(18):1264-7. Chinese.

PMID:
20646600
[PubMed - indexed for MEDLINE]
17.

EMMPRIN is an independent negative prognostic factor for patients with astrocytic glioma.

Tian L, Zhang Y, Chen Y, Cai M, Dong H, Xiong L.

PLoS One. 2013;8(3):e58069. doi: 10.1371/journal.pone.0058069. Epub 2013 Mar 13.

PMID:
23516431
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Evaluation of EMMPRIN and MMP-2 in the prognosis of primary cutaneous malignant melanoma.

Chen T, Zhu J.

Med Oncol. 2010 Dec;27(4):1185-91. doi: 10.1007/s12032-009-9357-y. Epub 2009 Nov 17.

PMID:
19921476
[PubMed - indexed for MEDLINE]
19.

Role of emmprin in endometrial cancer.

Nakamura K, Kodama J, Hongo A, Hiramatsu Y.

BMC Cancer. 2012 May 28;12:191. doi: 10.1186/1471-2407-12-191.

PMID:
22640183
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas.

Bi XC, Liu JM, He HC, Ye YK, Han ZD, Dai QS, Liang YX, Cai C, Chen JH, Chen XB, Qin GQ, Zeng GH, Zhong WD.

Clin Transl Oncol. 2012 Mar;14(3):190-6.

PMID:
22374422
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk